Barrington Research Reiterates Outperform on Imax, Maintains $24 Price Target
Portfolio Pulse from richadhand@benzinga.com
Barrington Research analyst James Goss has reiterated his 'Outperform' rating on Imax (NYSE:IMAX), maintaining a $24 price target.
July 28, 2023 | 1:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research has reiterated its 'Outperform' rating on Imax, maintaining a $24 price target.
The reiteration of the 'Outperform' rating by Barrington Research indicates a positive outlook for Imax. The maintained price target of $24 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100